title: Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
abstract: Tumor genome sequencing leads to documenting thousands of DNA mutations and other genomic alterations. At present, these data cannot be analyzed adequately to aid in the understanding of tumorigenesis and its evolution. Moreover, we have little insight into how to use these data to predict clinical phenotypes and tumor progression to better design patient treatment. To meet these challenges, we discuss a cancer hallmark network framework for modeling genome sequencing data to predict cancer clonal evolution and associated clinical phenotypes. The framework includes: (1) cancer hallmarks that can be represented by a few molecular/signaling networks. 'Network operational signatures' which represent gene regulatory logics/strengths enable to quantify state transitions and measures of hallmark traits. Thus, sets of genomic alterations which are associated with network operational signatures could be linked to the state/measure of hallmark traits. The network operational signature transforms genotypic data (i.e., genomic alterations) to regulatory phenotypic profiles (i.e., regulatory logics/strengths), to cellular phenotypic profiles (i.e., hallmark traits) which lead to clinical phenotypic profiles (i.e., a collection of hallmark traits). Furthermore, the framework considers regulatory logics of the hallmark networks under tumor evolutionary dynamics and therefore also includes: (2) a self-promoting positive feedback loop that is dominated by a genomic instability network and a cell survival/proliferation network is the main driver of tumor clonal evolution. Surrounding tumor stroma and its host immune systems shape the evolutionary paths; (3) cell motility initiating metastasis is a byproduct of the above self-promoting loop activity during tumorigenesis; (4) an emerging hallmark network which triggers genome duplication dominates a feed-forward loop which in turn could act as a rate-limiting step for tumor formation; (5) mutations and other genomic alterations have specific patterns and tissue-specificity, which are driven by aging and other cancer-inducing agents. This framework represents the logics of complex cancer biology as a myriad of phenotypic complexities governed by a limited set of underlying organizing principles. It therefore adds to our understanding of tumor evolution and tumorigenesis, and moreover, potential usefulness of predicting tumors' evolutionary paths and clinical phenotypes. Strategies of using this framework in conjunction with genome sequencing data in an attempt to predict personalized drug targets, drug resistance, and metastasis for cancer patients, as well as cancer risks for healthy individuals are discussed. Accurate prediction of cancer clonal evolution and clinical phenotypes will have substantial impact on timely diagnosis, personalized treatment and personalized prevention of cancer.
authors.affiliation: National Research Council Canada, Montreal, QC H4P 2R2, Canada; Center for Bioinformatics, McGill University, Montreal, QC H3G 0B1, Canada. Electronic address: edwin.wang@cnrc-nrc.gc.ca.
authors.forename: Edwin
authors.initials: E
authors.lastname: Wang
authors.affiliation: National Research Council Canada, Montreal, QC H4P 2R2, Canada; Department of Anatomy and Cell Biology, McGill University, Montreal, QC H3A 2B2, Canada.
authors.forename: Naif
authors.initials: N
authors.lastname: Zaman
authors.affiliation: National Research Council Canada, Montreal, QC H4P 2R2, Canada; Department of Experimental Medicine, McGill University, Montreal, QC H3A 1A3, Canada.
authors.forename: Shauna
authors.initials: S
authors.lastname: Mcgee
authors.affiliation: National Research Council Canada, Montreal, QC H4P 2R2, Canada; Department of Medicine, Laval University, Quebec, QC G1V 0A6, Canada.
authors.forename: Jean-Sébastien
authors.initials: JS
authors.lastname: Milanese
authors.affiliation: Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
authors.forename: Ali
authors.initials: A
authors.lastname: Masoudi-Nejad
authors.affiliation: National Research Council Canada, Montreal, QC H4P 2R2, Canada.
authors.forename: Maureen
authors.initials: M
authors.lastname: O'Connor-McCourt
mesh_terms: D053263:Gene Regulatory Networks / Q000235:genetics*; D015894:Genome, Human; D023281:Genomics / Q000379:methods*; D006801:Humans; D008957:Models, Genetic; D009369:Neoplasms / Q000235:genetics*; D010641:Phenotype; D057285:Precision Medicine / Q000379:methods*
keywords: Cancer hallmark; Cancer hallmark network framework; Cancer systems biology; Clinical phenotype; Drug resistance; Gene regulatory profile; Network; Network operational signature; Personalized medicine; Regulatory Phenotype; Tumor genome sequencing